相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis
M. A. Martinez-Garcia et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Trend from 2001 to 2015 in the prevalence of bronchiectasis among patients hospitalized for asthma and effect of bronchiectasis on the in-hospital mortality
Gema Sanchez-Munoz et al.
JOURNAL OF ASTHMA (2021)
Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients
J. Eklof et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
How does Pseudomonas aeruginosa affect the progression of bronchiectasis?
Y-H Chai et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease A Network Analysis
Miguel Angel Martinez-Garcia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Impact of Pseudomonas aeruginosa Isolation on Mortality and Outcomes in an Outpatient Chronic Obstructive Pulmonary Disease Cohort
David M. Jacobs et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Effectiveness and Safety of Omalizumab in Patients with Allergic Bronchopulmonary Aspergillosis Complicated by Chronic Bacterial Infection in the Airways
Katsuyoshi Tomomatsu et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2020)
The Link between Asthma and Bronchiectasis: State of the Art
Claudia Crimi et al.
RESPIRATION (2020)
Bacterial Community Interactions During Chronic Respiratory Disease
Allison L. Welp et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Lung function and microbiota diversity in cystic fibrosis
Leah Cuthbertson et al.
MICROBIOME (2020)
Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis
Meng-Jiao Xu et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2020)
Eradication of early P-aeruginosa infection in children <7 years of age with cystic fibrosis: The early study
Felix Ratjen et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Prognostic Value of Frequent Exacerbations in Bronchiectasis: The Relationship With Disease Severity
Miguel Angel Martinez-Garcia et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2019)
Transmission of bacteria in bronchiectasis and chronic obstructive pulmonary disease: Low burden of cough aerosols
Rebecca E. Stockwell et al.
RESPIROLOGY (2019)
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Sankalp Malhotra et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Population-based prevalence of bronchiectasis and associated comorbidities in South Korea
Hayoung Choi et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution
Joao Botelho et al.
DRUG RESISTANCE UPDATES (2019)
Heterogeneity and complexity in bronchiectasis: A pending challenge
Miguel Angel Martinez-Garcia et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2019)
Pseudomonas aeruginosa colonization causes PD-L1 overexpression on monocytes, impairing the adaptive immune response in patients with cystic fibrosis
Jose Avendano-Ortiz et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
British Thoracic Society Guideline for bronchiectasis in adults
Adam T. Hill et al.
THORAX (2019)
Persistence and Microevolution of Pseudomonas aeruginosa in the Cystic Fibrosis Lung: A Single-Patient Longitudinal Genomic Study
Irene Bianconi et al.
FRONTIERS IN MICROBIOLOGY (2019)
Pulmonary function patterns and their association with genotype and phenotype in adult cystic fibrosis patients
Dimitri Stylemans et al.
ACTA CLINICA BELGICA (2019)
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
Charles S. Haworth et al.
LANCET RESPIRATORY MEDICINE (2019)
Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis
Marina Blanco-Aparicio et al.
CHRONIC RESPIRATORY DISEASE (2019)
Efficacy of inhaled ciprofloxacin agents for the treatment of bronchiectasis: a systematic review and meta-analysis of randomized controlled trials
Jeong Uk Lim et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)
Characterization of the Frequent Exacerbator Phenotype in Bronchiectasis
James D. Chalmers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections
Nicholas M. Maurice et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Bronchiectasis in severe asthma Clinical features and outcomes
Isabel Coman et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Spanish Guidelines on Treatment of Bronchiectasis in Adults
Miguel Angel Martinez-Garcia et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2018)
The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis
David Araujo et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Anthony De Soyza et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Timothy Aksamit et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers
Miguel Angel Martinez-Garcia
EUROPEAN RESPIRATORY JOURNAL (2018)
Spanish Guidelines on Treatment of Bronchiectasis in Adults
Miguel Angel Martinez-Garcia et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2018)
Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis
Michael D. Parkins et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis
Nicole Acosta et al.
THORAX (2018)
Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice
Lindsay J. Caverly et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2018)
Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host?
Emmanuel Faure et al.
FRONTIERS IN IMMUNOLOGY (2018)
Investigation of bronchiectasis in severe uncontrolled asthma
Katerina Dimakou et al.
CLINICAL RESPIRATORY JOURNAL (2018)
Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients
A. Padilla-Galo et al.
RESPIRATORY RESEARCH (2018)
Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis
Taylor E. Woo et al.
ERJ OPEN RESEARCH (2018)
Bacterial Colonization in COPD Patients Admitted to a Rehabilitation Respiratory Unit and Impact on Length of Stay: A Real-Life Study
Michele Vitacca et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis
David de la Rosa Carrillo et al.
ERJ OPEN RESEARCH (2018)
Long-term clinical outcomes of 'Prairie Epidemic Strain' Pseudomonas aeruginosa infection in adults with cystic fibrosis
Ranjani Somayaji et al.
THORAX (2017)
Standardised classification of the aetiology of bronchiectasis using an objective algorithm
David Araujo et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
European Respiratory Society guidelines for the management of adult bronchiectasis
Eva Polverino et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study
Carla Lopez-Causape et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment
Juliana Durack et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis
J. E. Moore et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2017)
The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD
Janice M. Leung et al.
RESPIROLOGY (2017)
Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry
Casilda Olveira et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2017)
The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
Alya A. Heirali et al.
MICROBIOME (2017)
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis
Wynne D. Smith et al.
FEMS MICROBIOLOGY LETTERS (2017)
Bronchiectasis: Phenotyping a Complex Disease
James D. Chalmers
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
Simon C. Langton Hewer et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Clinical phenotypes in adult patients with bronchiectasis
Stefano Aliberti et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Asthma and risk of bronchiectasis exacerbation: we still need more evidence
Bei Mao et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Asthma and risk of bronchiectasis exacerbation: we still need more evidence
Yong-hua Gao et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Asthma and bronchiectasis exacerbation
Bei Mao et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Pulmonary Nontuberculous Mycobacteriosis and Chronic Lower Respiratory Tract Infections in Patients with Allergic Bronchopulmonary Mycosis without Cystic Fibrosis
Takashi Ishiguro et al.
INTERNAL MEDICINE (2016)
Unsupervised learning technique identifies bronchiectasis phenotypes with distinct clinical characteristics
W-J. Guan et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study
Juan de Dios Caballero et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes
Qingling Zhang et al.
PLOS ONE (2016)
Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis
Robert Wilson et al.
RESPIRATORY MEDICINE (2016)
Factors associated with radiologic progression of non-cystic fibrosis bronchiectasis during long-term follow-up
Jisoo Park et al.
RESPIROLOGY (2016)
Pseudomonas aeruginosa resistance patterns and clinical outcomes in hospitalized exacerbations of COPD
Ana Rodrigo-Troyano et al.
RESPIROLOGY (2016)
Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence
David de la Rosa et al.
CHRONIC RESPIRATORY DISEASE (2016)
The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis A Cluster Analysis Approach
Miguel A. Martinez-Garcia et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Divergent, Coexisting Pseudomonas aeruginosa Lineages in Chronic Cystic Fibrosis Lung Infections
David Williams et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Rafael Canton et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2015)
Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis
Nicole Mayer-Hamblett et al.
CLINICAL INFECTIOUS DISEASES (2015)
The increasing threat of Pseudomonas aeruginosa high-risk clones
Antonio Oliver et al.
DRUG RESISTANCE UPDATES (2015)
Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis
Thomas J. Evans
FUTURE MICROBIOLOGY (2015)
Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients
Rasmus Lykke Marvig et al.
FUTURE MICROBIOLOGY (2015)
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients
J. Stuart Elbom et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study
H. A. W. M. Tiddens et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Cystic fibrosis lung microbiome: Opportunities to reconsider management of airway infection
Lindsay J. Caverly et al.
PEDIATRIC PULMONOLOGY (2015)
Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis
Ramon Orriols et al.
RESPIRATION (2015)
Quality of Life and Bronchial Hyper-Responsiveness in Subjects With Bronchiectasis: Validation of the Seattle Obstructive Lung Disease Questionnaire in Bronchiectasis
Emel Bulcun et al.
Respiratory Care (2015)
Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance
Melissa J. McDonnell et al.
RESPIRATORY MEDICINE (2015)
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Rafael Canton et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2015)
Clinical Outcomes After Initial Pseudomonas Acquisition in Cystic Fibrosis
Edith T. Zemanick et al.
PEDIATRIC PULMONOLOGY (2015)
Lung microbiota across age and disease stage in cystic fibrosis
Bryan Coburn et al.
SCIENTIFIC REPORTS (2015)
A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis
Simon Finch et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
A Systematic Review of Factors Associated with Health-Related Quality of Life in Adolescents and Adults with Cystic Fibrosis
Al-Rahim R. Habib et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
Inhaled Colistin in Patients with Bronchiectasis and Chronic Pseudomonas aeruginosa Infection
Charles S. Haworth et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Pseudomonas aeruginosa In Vitro Phenotypes Distinguish Cystic Fibrosis Infection Stages and Outcomes
Nicole Mayer-Hamblett et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
The Bronchiectasis Severity Index An International Derivation and Validation Study
James D. Chalmers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Early Respiratory Infection Is Associated with Reduced Spirometry in Children with Cystic Fibrosis
Kathryn A. Ramsey et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis
Anthony De Soyza et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score
Miguel A. Martinez-Garcia et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Does a single Pseudomonas aeruginosa isolation predict COPD mortality?
Afroditi K. Boutou et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Potentially Pathogenic Airway Bacteria and Neutrophilic Inflammation in Treatment Resistant Severe Asthma
Benjamin J. Green et al.
PLOS ONE (2014)
Mortality in non-cystic fibrosis bronchiectasis: A prospective cohort analysis
P. C. Goeminne et al.
RESPIRATORY MEDICINE (2014)
Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis
Luke D. Knibbs et al.
THORAX (2014)
Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors
Miguel Gallego et al.
BMC PULMONARY MEDICINE (2014)
Longitudinal Trends in Health-Related Quality of Life in Adults With Cystic Fibrosis
Edward J. Dill et al.
CHEST (2013)
Chronic obstructive pulmonary disease and bronchiectasis
Shannon A. Novosad et al.
CURRENT OPINION IN PULMONARY MEDICINE (2013)
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
Robert Wilson et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials
Luis Maiz et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial
Baroukh M. Assael et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis
M. Proesmans et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
Edith T. Zemanick et al.
PLOS ONE (2013)
Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa
Jeremy R. Dettman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Chronic bronchial infection in COPD. Is there an infective phenotype?
Zinka Matkovic et al.
RESPIRATORY MEDICINE (2013)
Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life
Casilda Olveira et al.
QUALITY OF LIFE RESEARCH (2013)
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
Antje Schuster et al.
THORAX (2013)
Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
J. P. Clancy et al.
THORAX (2013)
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
David J. Serisier et al.
THORAX (2013)
Pseudomonas aeruginosa: new insights into pathogenesis and host defenses
Shaan L. Gellatly et al.
PATHOGENS AND DISEASE (2013)
Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non-Cystic Fibrosis Bronchiectasis
James D. Chalmers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis
Peter Greally et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
High-resolution computed tomography scores in cystic fibrosis patients colonized with Pseudomonas aeruginosa or Staphylococcus aureus
Tania Wrobel Folescu et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2012)
Risk factors for rate of decline in FEV1 in adults with cystic fibrosis
Michael W. Konstan et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
Gerd Doering et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis
Clement L. Ren et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Analysis of the associations between lung function and clinical features in preschool children with Cystic Fibrosis
Clement L. Ren et al.
PEDIATRIC PULMONOLOGY (2012)
Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution
Gregory S. Sawicki et al.
PEDIATRIC PULMONOLOGY (2012)
Pseudomonas aeruginosa and Mortality after Hospital Admission for Chronic Obstructive Pulmonary Disease
Pedro Almagro et al.
RESPIRATION (2012)
Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis
Laura White et al.
RESPIRATORY MEDICINE (2012)
Bacteria in sputum of stable severe asthma and increased airway wall thickness
Qingling Zhang et al.
RESPIRATORY RESEARCH (2012)
Progression of early structural lung disease in young children with cystic fibrosis assessed using CT
Lauren S. Mott et al.
THORAX (2012)
Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study
David Taylor-Robinson et al.
THORAX (2012)
Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols
Giovanni Taccetti et al.
THORAX (2012)
Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma
D. Menzies et al.
ALLERGY (2011)
Infection, Inflammation, and Lung Function Decline in Infants with Cystic Fibrosis
Naveen Pillarisetti et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis with Pseudomonas aeruginosa
David E. Geller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
A Randomized Controlled Trial of Nebulized Gentamicin in Non-Cystic Fibrosis Bronchiectasis
Maeve P. Murray et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Bronchiectasis and Pulmonary Exacerbations in Children and Young Adults With Cystic Fibrosis
Martine Loeve et al.
CHEST (2011)
Inflammatory Responses to Individual Microorganisms in the Lungs of Children With Cystic Fibrosis
Catherine Gangell et al.
CLINICAL INFECTIOUS DISEASES (2011)
390 Efficacy and safety of colistin for inhalation in children 5 years old and younger with cystic fibrosis with Pseudomonas aeruginosa infection
V Nikonova et al.
Journal of Cystic Fibrosis (2011)
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
C. E. Wainwright et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies
Maarten Fauvart et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Longitudinal Assessment of Health-Related Quality of Life in an Observational Cohort of Patients With Cystic Fibrosis
Gregory S. Sawicki et al.
PEDIATRIC PULMONOLOGY (2011)
Outpatient Treatment of Pseudomonas aeruginosa Bronchial Colonization with Long-term Inhaled Colistin, Tobramycin, or Both in Adults without Cystic Fibrosis
David Berlana et al.
PHARMACOTHERAPY (2011)
Inhaled antibiotics for long-term therapy in cystic fibrosis
G. Ryan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Validation of the Spanish Version of the Revised Cystic Fibrosis Quality of Life Questionnaire in Adolescents and Adults (CFQR 14+Spain)
Gabriel Olveira et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2010)
The Changing Microbial Epidemiology in Cystic Fibrosis
John J. LiPuma
CLINICAL MICROBIOLOGY REVIEWS (2010)
Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy
Antonio Oliver
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis
Nina Cramer et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2010)
The Accessory Genome of Pseudomonas aeruginosa
Vanderlene L. Kung et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2010)
Baseline Characteristics and Factors Associated With Nutritional and Pulmonary Status at Enrollment in the Cystic Fibrosis EPIC Observational Cohort
Margaret Rosenfeld et al.
PEDIATRIC PULMONOLOGY (2010)
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial
Felix Ratjen et al.
THORAX (2010)
Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa
R. Dhar et al.
THORAX (2010)
Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection
Alexandra L. Quittner et al.
CHEST (2009)
Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
George Z. Retsch-Bogart et al.
CHEST (2009)
Qualitative Analysis of High-Resolution CT Scans in Severe Asthma
Sumit Gupta et al.
CHEST (2009)
Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease
Timothy F. Murphy
CURRENT OPINION IN PULMONARY MEDICINE (2009)
Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis
T. A. Douglas et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study
C. Garcia-Vidal et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival
M. R. Loebinger et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Mortality of COPD Patients Infected with Multi-Resistant Pseudomonas aeruginosa: A Case and Control Study
M. Montero et al.
INFECTION (2009)
Pseudomonas aeruginosa Population Biology in Chronic Obstructive Pulmonary Disease
Elza Rakhimova et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Cystic Fibrosis HRCT Scores Correlate Strongly With Pseudomonas Infection
Terry E. Robinson et al.
PEDIATRIC PULMONOLOGY (2009)
Effect of Mutator P. aeruginosa on Antibiotic Resistance Acquisition and Respiratory Function in Cystic Fibrosis
Agnes Ferroni et al.
PEDIATRIC PULMONOLOGY (2009)
The Approach to Pseudomonas aeruginosa in Cystic Fibrosis
Glenda N. Bendiak et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis
Karen S. McCoy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
The Many Faces of Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease
Timothy F. Murphy
CLINICAL INFECTIOUS DISEASES (2008)
Chronic Pseudomonas aeruginosa Infection in Chronic Obstructive Pulmonary Disease
Laura Martinez-Solano et al.
CLINICAL INFECTIOUS DISEASES (2008)
Pseudomonas aeruginosa diversity in distinct paediatric patient groups
G. A. Tramper-Stranders et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients
B. Ryall et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience
C. R. Hansen et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population
Richard Bradbury et al.
RESPIROLOGY (2008)
Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis
Miguel Angel Martinez-Garcia et al.
CHEST (2007)
Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis
Michael W. Konstan et al.
JOURNAL OF PEDIATRICS (2007)
Microbiologic follow-up study in adult bronchiectasis
Paul T. King et al.
RESPIRATORY MEDICINE (2007)
Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis
D. P. Steinfort et al.
INTERNAL MEDICINE JOURNAL (2007)
A prediction model for bacterial etiology in acute exacerbations of COPD
H. Lode et al.
INFECTION (2007)
Predictors of mortality in adults with cystic fibrosis
J. M. Courtney et al.
PEDIATRIC PULMONOLOGY (2007)
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis
Diana Bilton et al.
CHEST (2006)
The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
G. Davies et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients
G Taccetti et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease
A Rosell et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis
ZH Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients
R Canton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa
ME Drobnic et al.
ANNALS OF PHARMACOTHERAPY (2005)
Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa
SD Aaron et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection
AG Drannik et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening
JH Maselli et al.
PEDIATRIC PULMONOLOGY (2003)
Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management
M Rosenfeld et al.
CURRENT OPINION IN PULMONARY MEDICINE (2003)
Inhaled tobramycin (TOBI (R)) - A review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis
SM Cheer et al.
DRUGS (2003)
Early airway infection, inflammation, and lung function in cystic fibrosis
GM Nixon et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2002)
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis
ME Hodson et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis
J Emerson et al.
PEDIATRIC PULMONOLOGY (2002)
Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis -: Early detection by serology and assessment of risk factors
SEH West et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Pulmonary function and quality of life in relation to bronchial colonization in adults with bronchiectasis not caused by cystic fibrosis
C Hernández et al.
MEDICINA CLINICA (2002)
Antibiotic prophylaxis in infants and young children with cystic fibrosis: A randomized controlled trial
HR Stutman et al.
JOURNAL OF PEDIATRICS (2002)
Exhaled H2O2 in steady-state bronchiectasis - Relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease
S Loukides et al.
CHEST (2002)
Bronchial inflammation and colonization in patients with clinically stable bronchiectasis
J Angrill et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition
MR Kosorok et al.
PEDIATRIC PULMONOLOGY (2001)
Treatment with tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa
LA Couch
CHEST (2001)
Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF
J Navarro et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis
GM Nixon et al.
JOURNAL OF PEDIATRICS (2001)
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis
JL Burns et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis
JP Gutierrez et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
The treatment of respiratory pseudomonas infection in cystic fibrosis - What drug and which way?
D Banerjee et al.
DRUGS (2000)
Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis
AF Barker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
分享论文
